Galena Biopharma Inc (NASDAQ:GALE) jumped 14.02% after news that it has acquired Mills Pharmaceuticals, which has the worldwide rights to GALE-401 (Anagrelide CR), a patented, controlled release formulation of anagrelide. The company expects to pursue the expedited 505(b)(2) regulatory pathway to seek approval of GALE-401 for the treatment of Essential Thrombocythemia (ET). Galena Biopharma Inc (NASDAQ:GALE) stock opened at $6.80 in last session, and closed at $7.24, while the day range of stock is $6.75 – $7.60. The stock showed a positive weekly performance of 3.84%.
Barclays restated their equal weight rating on shares of Idenix Pharmaceuticals Inc (NASDAQ:IDIX) in a report issued on Friday, AR Network reports. Idenix Pharmaceuticals Inc (NASDAQ:IDIX) stock opened at $6.90, in last session and closed at $6.45, by losing -1.38%. The 52 week range of the stock is $2.93 – $7.48. Company’s market capitalization is $864.30 billion.
Sirius XM Holdings Inc. (NASDAQ:SIRI) disclosed that it had 25.56 million subscribers vis-a-vis 25.82 million members three months back. The firm is targeting another 1.25 million net subscriber additions as well as $1.1 billion in free cash flow in 2014. Sirius XM Holdings Inc. (NASDAQ:SIRI) stock decreased -0.81% and finished the last session at $3.67. The EPS of the stock remained 0.07. Company’s market capitalization is $22.70 billion.
CRT Capital reissued their fair value rating on shares of Pandora Media (NYSE:P) in a research report sent to investors on Friday morning, Stock Ratings News reports. The firm currently has a $35.00 price target on the stock. Pandora Media Inc (NYSE:P) stock opened the session at $33.36, and closed the session at $32.53. The 52 week range of the stock remained $10.10 – $34.46 and the day range was $32.06 – $34.07.